ORCL
67
2
KMX
64
6
HOG
33
4
HD
55
8
LB
41
7
AMGN
38
-6
GM
68
3
HST
58
18
NRG
52
3
AIG
44
6
ACN
49
2
FOXA
59
4
XEL
69
2
IVZ
48
2
A
41
5
CMS
60
2
XYL
45
8
AXP
69
3
KMI
69
2
PEG
67
5
ORCL
67
2
KMX
64
6
HOG
33
4
HD
55
8
LB
41
7
AMGN
38
-6
GM
68
3
HST
58
18
NRG
52
3
AIG
44
6
ACN
49
2
FOXA
59
4
XEL
69
2
IVZ
48
2
A
41
5
CMS
60
2
XYL
45
8
AXP
69
3
KMI
69
2
PEG
67
5
Financhill
Back

GlycoMimetics Vs. Revance Therapeutics Industry Stock Comparison

Sell
47

GLYC
GlycoMimetics

Last Price:
0.32
Seasonality Move:
31.73%
Sell
10

RVNC
Revance Therapeutics

Last Price:
3.73
Seasonality Move:
2.15%
Sell
47
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

  • The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
10
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.84. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

  • The GlycoMimetics share price today is $0.32
    The current trend is moderately bearish and GLYC is experiencing slight buying pressure.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.

GLYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 47.99 Sell
Chaikin Money Flow: 366577 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.23 - 0.45) Sell
Bollinger Bands (100): (0.14 - 0.32) Buy

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 34.28 Sell
Chaikin Money Flow: 227722 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.06 - 5.8) Sell
Bollinger Bands (100): (3.74 - 6.28) Sell

GLYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.38 Sell
20-day SMA: 0.38 Sell
50-day SMA: 0.25 Buy
200-day SMA: 0.98 Sell
8-day EMA: 0.37 Sell
20-day EMA: 0.35 Sell
50-day EMA: 0.3 Buy
200-day EMA: 0.74 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.03 Sell
20-day SMA: 4.84 Sell
50-day SMA: 5.22 Sell
200-day SMA: 4.61 Sell
8-day EMA: 4.07 Sell
20-day EMA: 4.56 Sell
50-day EMA: 4.97 Sell
200-day EMA: 6.03 Sell

GlycoMimetics Earnings Growth & GLYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

GlycoMimetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):